Double blind placebo controlled trial of pulse treatment with methylprednisolone combined with disease modifying drugs in rheumatoid arthritis.

OBJECTIVE--To assess whether monthly treatment with intravenous methylprednisolone enhances or accelerates the effect of disease modifying drugs in patients with rheumatoid arthritis. DESIGN--A 12 month double blind, placebo controlled, multicentre trial in which patients with active rheumatoid arth...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Hansen, T M, Kryger, P, Elling, H, Haar, D, Kreutzfeldt, M, Ingeman-Nielsen, M W, Olsson, A T, Pedersen, C, Rahbek, A, Tvede, N
Médium: Artigo
Jazyk:Inglês
Vydáno: 1990
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1663457/
https://ncbi.nlm.nih.gov/pubmed/2202458
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky